Should you buy Bristol-Myers Squibb Company stock? (NYSE:BMY). Let's see how it does in our automated value investing analysis system.
Based on historical returns, we believe that Bristol-Myers Squibb Company can grow its free cash at a rate of about 5%. That's positive!
(Bristol-Myers Squibb Company stock price per share)
||BMY Fair Price
(based on intrinsic value)
||BMY Safety Price (based on a variable margin of safety)||$10.76|
||PE Ratio versus Sector||316% higher than other Healthcare stocks|
|PE Ratio versus Industry||390% higher than other Drug Manufacturers - Major stocks|
|Free Cash Flow Jitter||72%|
We believe that Bristol-Myers Squibb Company may be worth examining further. It's making money, which is a very positive sign. Is it on sale?
Bristol-Myers Squibb Company looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.
Does Bristol-Myers Squibb Company have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
Most Popular Articles